18F]FE-PE2I

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	3

6. パーキンソン病

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

trials per page:

Showing 1 to 3 of 3 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2015-003045-26-SE (EUCTR)	23/10/2015	15/09/2015	Study of Dopamine Transporters (signal substance in central nervous system)in patients with early si ...	[18F] FE-PE2I PET/CT study of Dopamine Transporters in Early Parkinsonian disease.	Patients with newly clinically diagnosed untreated idiopathic parkinsonism MedDRA version: 20.0;Leve ...	Product Name: [18F]FE-PE2I INN or Proposed INN: [18F]-(E)-N-(3-iodoprop-2-enyl)-2b-carbofluoroethoxy- ...	Umeå University Hospital	NULL	Not Recruiting			Female: yes Male: yes	105	Phase 2	Sweden
2	EUCTR2011-004803-19-FI (EUCTR)	16/08/2012	16/05/2012	PET study in PD patients	A Phase IIA, Multi centre, Double-blind, Randomised, Placebo-controlled, Parallel-group Study to Ass ...	Parkinson's Disease; Microglia activation as measured by [11C]PBR28 binding to TSPO MedDRA version: ...	Product Name: AZD3241 Extended release tablets 25 mg Product Code: AZD3241 Product Name: AZD3241 Exten ...	AstraZeneca AB	NULL	Not Recruiting			Female: yes Male: yes	24	Phase 2	Finland;Sweden
3	EUCTR2011-004803-19-SE (EUCTR)	22/02/2012	16/12/2011	PET study in PD patients	A Phase IIA, Multi centre, Double-blind, Randomised, Placebo-controlled, Parallel-group Study to Ass ...	Parkinson's Disease; Microglia activation as measured by [11C]PBR28 binding to TSPO MedDRA version: ...	Product Name: AZD3241 Extended release tablets 25 mg Product Code: AZD3241 Product Name: AZD3241 Exten ...	AstraZeneca AB	NULL	Not Recruiting			Female: yes Male: yes	24	Phase 2	Finland;Sweden

First Previous1Next Last